[1] RAPTOPOULOU M,PAPATHEODORIDIS G,ANTONIOU A,et al.Epidemiology,course and disease burden of chronic hepatitis Bvirus infection.HEPNET study for chronic hepatitis B:a multicentre Greek study[J].J Viral Hepat,2009,16(3):195-202.
|
[2]LIANG P,ZU J,YIN J,et al.The independent impact of newborn hepatitis B vaccination on reducing HBV prevalence in China,1992-2006:a mathematical model analysis[J].J Theor Biol,2015,386:115-121.
|
[3]GUO TZ,HAN LX,LUO Y,et al.Risk factors of liver cancer in patients with hepatitis B virus infection[J].Int J Virol,2016,23(1):26-28.(in Chinese)郭铁志,韩立新,罗研,等.乙型肝炎病毒感染患者肝癌发病的影响因素研究[J].国际病毒学杂志,2016,23(1):26-28.
|
[4] WU JF,CHANG MH.Natural history of chronic hepatitis B virus infection from infancy to adult life-the mechanism of inflammation triggering and long-term impacts[J].J Biomed Sci,2015,22(1):92.
|
[5]LIAW YF,KAO JH,PIRATVISUTH T,et al.Asian-Pacific consensus statement on the management of chronic hepatitis B:a 2012 update[J].Hepatol Int,2012,6(3):531-561.
|
[6]MARTIN P,LAU DT,NGUYEN MH,et al.A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States:2015 Update[J].Clin Gastroenterol Hepatol,2015,13(12):2071-2087.
|
[7]PARK JY,PARK YN,KIM DY,et al.High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels[J].J Viral Hepat,2008,15(8):615-621.
|
[8] CHEONG JY,KIM D J,HWANG SG,et al.Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels[J].Liver Int,2011,31(9):1352-1358.
|
[9] ALAM MM,MAHTAB MA,AKBAR SM,et al.Hepatic necroinflammation and severe liver fibrosis in patients with chronic hepatitis B with undetectable HBV DNA and persistently normal alanine aminotransferase[J].Bangladesh Med Res Counc Bull,2014,40(3):92-96.
|
[10]XIANG TX,TAO XP,LI XN,et al.Study on interferon gamma spot level of chronic hepatitis B infection in different immune stages and optimal opportunity of antiviral treatment in low levels of ALT patients[J].Int J Virol,2015,22(3):157-161.(in Chinese)向天新,陶学萍,李细女,等.慢性乙肝病毒感染者不同免疫阶段IFN-γ斑点水平及其他低丙氨酸氨基转移酶抗病毒治疗中的作用[J].国际病毒学杂志,2015,22(3):157-161.
|
[11] Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B(2010 verson)[J].J Clin Hepatol,2011,27(1):Ⅰ-ⅩⅥ.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版)[J].临床肝胆病杂志,2011,27(1):Ⅰ-ⅩⅥ.
|
[12]Chinese Society of Hepatology and Chinese Society of Infectious Diseases and Parasitic Disease,Chinese Medical Association.Guideline:prevention and treatment of viral hepatitis(draft)[J].Chin JHepatol,2000,8(6):324-329.(in Chinese)中华医学会传染病与寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329.
|
[13]MYERS RP,TAINTURIER MH,RATZIU V,et al.Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B[J].J Hepatol,2003,39(2):222-230.
|
[14]BENINI F,PIGOZZI MG,BAISINI O,et al.Increased serum gamma-glutamyl-transpeptidase concentration is associated with nonalcoholic steatosis and not with cholestasis in patients with chronic hepatitis C[J].J Gastroenterol Hepatol,2007,22(10):1621-1626.
|
[15] KRISHNAMURTHY HA.The serum gamma glutamyl transpeptidasea non invasive diagnostic bio marker of chronic anicteric non alcoholic liver diseases[J].J Clin Diagn Res,2013,7(4):691-694.
|